Report Materials
Why OIG Did This Audit
The Provider Relief Fund (PRF) provides funds to eligible providers for health care-related expenses or lost revenue attributable to COVID 19. HHS was responsible for PRF program oversight and policy decisions, and the Health Resources and Services Administration (HRSA) provided day-to-day oversight of the program from April 10 through April 24, 2020 (audit period).
Providers that received automatic PRF payments under the Phase 1 General Distribution were subject to several program requirements, such as not having their Medicare billing privileges revoked. To ensure that providers receive the correct PRF payments from the Phase 1 General Distribution, HHS and HRSA established oversight procedures related to these requirements.
End of
Translation
This audit is part of OIG's oversight of HHS's COVID-19 response and recovery efforts.
Our objective was to determine whether HHS ensured that Phase 1 automatic General Distribution automatic PRF payments were: (1) properly calculated and (2) disbursed only to eligible providers.
How OIG Did This Audit
Our audit covered approximately $39 billion in automatic PRF payments that were disbursed to 319,468 providers during our audit period. We performed audit procedures, including interviewing HRSA officials and contractors and analyzing payment data.
What OIG Found
HHS allocated PRF funds in a series of distributions in several phases. Of relevance to this audit, HHS allocated $50 billion to distribute to providers in two rounds under the Phase 1 General Distribution for eligible providers that billed Medicare fee-for-service. Most of these payments were automatically made to these providers (i.e., providers did not need to take action to receive payments).
Generally, HHS's oversight was effective in ensuring that most of the approximately $39.3 billion in automatic PRF payments were properly calculated and disbursed to eligible providers. However, HHS did not ensure that approximately $2.16 billion (5.5 percent) in automatic PRF payments were properly calculated as intended. Also, HHS did not prevent more than $247 million in payments (less than 1 percent) from being disbursed to ineligible providers and did not utilize all readily available lists to identify these providers. Specifically, we found that HHS did not ensure that all round 1 automatic PRF payments to Medicare providers were properly calculated as intended. Additionally, HHS did not ensure that calculations for round 2 automatic PRF payments were properly made to Medicare providers. Finally, HHS did not identify all ineligible providers and exclude them from receiving PRF payments.
We understand that HHS and HRSA's operational objective at the beginning of the COVID-19 national emergency was to rapidly disburse PRF payments to support providers facing severe economic hardship during the national emergency. We also understand that HHS prioritized the rapid distribution of PRF payments and did not focus its activities on lowering the risk of improper payments because those activities would have delayed the disbursement of PRF payments. However, as HRSA fully develops and implements post payment review processes, it should consider the information and recommendations included in this report.
What OIG Recommends and HRSA Comments
We made a series of recommendations to HRSA, including that it perform post payment quality control reviews of selected providers and recoup any overpayments. (The full text of our recommendations is shown in the report.) HRSA concurred with all of our recommendations and provided information on actions that it had taken or plans to take to address them.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.